Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.